AI Empowers Patients to Navigate Cancer Care
An AACR Patient Advocate Forum assembled a panel of experts to discuss how AI tools can help advance cancer...
An AACR Patient Advocate Forum assembled a panel of experts to discuss how AI tools can help advance cancer...
The flurry of treatments approved by the U.S. Food and Drug Administration (FDA) for treating hematological malignancies continued last...
Today, the American Association for Cancer Research (AACR) released its seventh annual Cancer Progress Report. The report highlights how...
When runners cross the starting line at the AACR Rock ‘n’ Roll Philadelphia races later this month, several will...
This week, some of the world’s leading cancer researchers are gathering in Mainz/Frankfurt, Germany for the Third International Cancer...
This week’s excitement surrounding the groundbreaking U.S. Food and Drug Administration (FDA) approval of the CAR T–cell therapy tisagenlecleucel...
Yesterday marked a much anticipated milestone for the oncology community: The U.S. Food and Drug Administration (FDA) announced the...
A pair of studies published recently in journals of the American Association for Cancer Research bring to our attention...
Earlier this year, a study published in Cancer Discovery, a journal of the American Association for Cancer Research (AACR),...
A major objective of former Vice President Joe Biden’s National Cancer Moonshot Initiative is breaking down silos and sharing...
This week, the U.S. Food and Drug Administration (FDA) added two new treatments to the armamentarium for hematologic oncologists...